30 Archives - ARC Group

News

Biotech Theolytics Relocates to ARC Oxford

Daiichi Sankyo gets go-ahead for acute myeloid leukaemia treatment

TRADITIONAL LAB DESIGN NOT ADDRESSING SENSORY PROCESSING NEEDS OF NEURODIVERSE MINDS

Epsilogen completes £12.5 million Series B financing expansion

The Science of Business Returns

YELLOWSTONE BIOSCIENCES LAUNCHES AT ARC OXFORD

ARC supports the drive to revive Oxford-Cambridge high-tech growth plan

Oxford BioDynamics shortlisted for a strategic Government initiative to improve cancer immunotherapy.

Amgen secures first fast paced approval for life-saving new medicine

ARC OXFORD UNVEILS NEXT GENERATION ASCENT DEVELOPMENT

Accession Therapeutics raises £25m

Parexel named Best Contract Research Organisation

The UK has a life science literacy problem that goes beyond investors

Motherlabs Community Grows

Pioneering tomorrow’s science with inclusive lab spaces

EPSILOGEN AND LONZA ACHIEVE MANUFACTURING MILESTONE WITH OVARIAN CANCER THERAPY

ARC Uxbridge Delivers a For Pizza Express and JATO Dynamics

The UK needs to swot up if it wants to keep its science startups

ARC secures over 50 percent of all leasing transactions across Oxfordshire in 2023

Fortnum and Mason and Ivy Farm collaborate on the future of farming

SELOXIUM JOINS GROWING SCIENCE COMMUNITY AT ARC OXFORD

FluoRok awarded £750k grant by UKRI’s Faraday Battery Challenge

Fluorok becomes latest member to join ARC Oxford as university spin-out scales

ARC CEO comments on Atomico’s State of European Tech report

Redefining Lab Life as structure completed for landmark ARC West London lab development.

ARC Appoints Sebastian Johnson To Support Growing Ecosystem

UK confirmed to rejoin Horizon Europe

EPSILOGEN RESULTS PAVE THE WAY TO DEVELOPMENT OF NEW CLASS OF ANTI-CANCER DRUG

ARC takes finalist spot at Hustle Awards

A £650m funding package for the UK’s life sciences ecosystem welcomed by ARC

Ultromics granted FDA Breakthrough Device Designation

you’ve seen 60 of 80 News

1
2
3